Radiotherapy with or Without Concomitant Temozolomide for Brain Metastases of Non-Small Cell Lung Cancer
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2012
Price : $35 *
At a glance
- Drugs Temozolomide (Primary)
- Indications Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Nov 2012 New trial record
- 29 Sep 2012 Interim results (n=20) presented at the 37th Congress of the European Society for Medical Oncology.
- 29 Sep 2012 Recruitment is ongoing and to date 20 patients have been included.